PDT Partners’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-105,566
Closed -$3.62M 752
2024
Q1
$3.62M Sell
105,566
-19,113
-15% -$690K 0.34% 78
2023
Q4
$4.6M Hold
124,679
0.51% 34
2023
Q3
$2.53M Sell
124,679
-33,396
-21% -$734K 0.32% 94
2023
Q2
$3.23M Buy
158,075
+13,044
+9% +$195K 0.44% 50
2023
Q1
$2.19M Buy
+145,031
New +$3.2M 0.3% 112
2021
Q4
Sell
-47,400
Closed -$5.07M 1020
2021
Q3
$5.07M Buy
47,400
+2,100
+5% +$240K 0.36% 62
2021
Q2
$6.04M Buy
45,300
+16,987
+60% +$1.97M 0.4% 24
2021
Q1
$3.51M Sell
28,313
-1,147
-4% -$174K 0.25% 161
2020
Q4
$4.16M Sell
29,460
-27,754
-49% -$3.08M 0.28% 168
2020
Q3
$4.35M Sell
57,214
-1,886
-3% -$117K 0.29% 145
2020
Q2
$2.68M Buy
59,100
+39,366
+199% +$1.41M 0.18% 181
2020
Q1
$603K Sell
19,734
-20,516
-51% -$552K 0.05% 329
2019
Q4
$845K Buy
40,250
+934
+2% +$21.9K 0.05% 313
2019
Q3
$939K Buy
39,316
+21,516
+121% +$625K 0.06% 290
2019
Q2
$516K Buy
+17,800
New +$471K 0.03% 303

Other funds holding TWST

PDT Partners's TWST Position: Q2 2024 in Review

PDT Partners sold out of Twist Bioscience (TWST) in Q2 2024, closing a stake of 105,566 shares — an estimated $3.62M sold.

PDT Partners first reported a position in TWST in Q2 2019 and held it in 15 quarters. The position peaked at $6.04M in Q2 2021. 262 funds tracked by Wall St. Rank hold TWST as of Q2 2024.

  • PDT Partners reported no remaining Twist Bioscience position as of Q2 2024 after selling out during the quarter.
  • PDT Partners sold 105,566 Twist Bioscience shares in Q2 2024, an estimated $3.62M.
  • PDT Partners first reported a position in Twist Bioscience in Q2 2019 and held it in 15 quarters.
  • PDT Partners's Twist Bioscience position peaked at $6.04M in Q2 2021.
  • 262 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2024.

Based on PDT Partners's 13F filing for Q2 2024, filed 15 Aug 2024.